Release Date: May 2013
Expiration Date: May 2014
Continue Reading
Estimated time to complete the educational activity: 1 hour
This activity is jointly sponsored by Medical Education Resources and Haymarket Medical Education.
Statement of Need: Treatment of BPH-related LUTS has evolved from surgical therapy to medical monotherapy, and now combination therapy. Urologists and support staff who treat patients with BPH need to be aware of current combination therapy protocols in the management of male LUTS.
Target Audience: This activity has been designed to meet the needs of urologists, and allied healthcare clinicians who treat patients with bladder outlet obstruction.
Educational Objectives: After completing the activity, the participant should be better able to:
- Assess treatment options in males with benign prostatic hyperplasia, based on severity of voiding symptoms.
- Identify varying oral agents used in the management of bladder outlet obstruction.
Accreditation Statement:This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Medical Education Resources (MER) and Haymarket Medical Education. MER is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation:Medical Education Resources designates this enduring materialfor a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the creditcommensurate with the extent of their participation in the activity.
Disclosure of Conflicts of Interest: Medical Education Resources ensures balance, independence, objectivity, and scientific rigor in all our educational programs. In accordance with this policy, MER identifies conflicts of interest with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Conflicts are resolved by MER to ensure all scientific research referred to, reported, or used in a CME activity conforms to the generally accepted standards of experimental design, data collection, and analysis. MER is committed to providing its learners with high-quality CME activities that promote improvements or quality in health care and not a commercial interest.
The faculty reported the following financial relationships with commercial interests whose products or services may be mentioned in this CME activity:
| Name of Faculty | Reported Financial Relationship |
| Bilal Chughtai, MD Steven A. Kaplan, MD |
No financial relationships to disclose Research Support: Pfizer |
The content managers, Jody A. Charnow and Marina Galanakis, of Haymarket Medical Education, and Julie Johnson, PharmD, of Medical Education Resources, have disclosed that they have no relevant financial relationships or conflicts of interest.
Method of Participation: There are no fees for participating in and receiving CME credit for this activity. During the period May 2013 through May 2014, participants must: 1) read the learning objectives and faculty disclosures, 2) study the educational activity, 3) complete the posttest and submit it online. Physicians may register at http://www.myCME.com/renalandurologynews, and 4) complete the evaluation form online.
A statement of credit will be issued only upon receipt of a completed activity evaluation form and a completed post-test with a score of 70% or better.
